Top Markets
#1 Akedo Akedo +61.65%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.50%
#4 Cross Cross +46.58%
#5 Black Phoenix Black Phoenix +34.22%
#6 Velvet Velvet +31.90%
#7 OVERTAKE OVERTAKE +27.47%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.31%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +14.54%
#10 Movement Movement +13.62%
Coin of the day
Akedo Akedo
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc.

BLCM
Classificação em ações #38880
Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage... Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage biopharmaceutical firm dedicated to pioneering and advancing innovative cellular immunotherapies. Its primary objective is to combat blood cancers and solid tumors across domestic and global markets. Among its pipeline of experimental therapies are two key GoCAR-T candidates currently undergoing Phase 1/2 clinical evaluations. BPX-601, an autologous therapy, targets solid tumors that exhibit the prostate stem cell antigen. Additionally, BPX-603, a dual-switch GoCAR-T treatment, is being investigated for solid tumors characterized by the human epidermal growth factor receptor 2 (HER2) antigens. The company also features Rivo-cel, an allogeneic T cell therapy designed to improve patient prognoses in cases of leukemias, lymphomas, and various inherited blood disorders. Bellicum maintains strategic partnerships and licensing arrangements with several entities, including Adaptimmune Therapeutics plc, Agensys, Inc., BioVec Pharma, Inc., ARIAD Pharmaceuticals, Inc., and Baylor College of Medicine. Established in 2004, the company's corporate headquarters are located in Houston, Texas.
Preço da ação
$0.07475
Última sincronização: 2024-03-04
Valor de mercado
$755.60K
Variação (1 dia)
-6.68%
Variação (1 ano)
0.00%
País
US
Negociar Bellicum Pharmaceuticals, Inc. (BLCM)

Categoria

Healthcare
Histórico de preços das ações de Bellicum Pharmaceuticals, Inc. (BLCM)
Preço de fecho mais alto: $0.08 em 2024-03-01

Preço de fecho mais baixo: $214.46 em 2014-12-01
Histórico de preços das ações da Bellicum Pharmaceuticals, Inc. de 2014 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2024 -58.98%
2023 -77.47%
2022 -48.69%
2021 -48.79%
2020 -67.81%
2019 -72.37%
2018 -59.58%
2017 -43.00%
2016 -22.19%
2015 -6.78%
2014 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $507.69 30.08%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $848.55 30.06%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE